March 21, 2008 - The FDA gave conditional approval to PLC Systems to begin enrollment in a U.S. pivotal trial to study the effectiveness of RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy (CIN).

March 21, 2008 – A central Ohio man has become the first person in the U.S., and only the 16th worldwide, to receive a heart implant called the CardioKinetix VPD Implant System designed to improve the heart’s pumping action and help manage congestive heart failure symptoms.

March 21, 2008 - Cordis Corp. has received 510(k) marketing clearance from the FDA for the S.M.A.R.T. Nitinol Stent Transhepatic Biliary System for lengths of 120 mm and 150 mm, the company reported at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology (SIR) meeting.

March 18, 2008 - Cardinal Health and GE Healthcare penned a deal to broaden the availability of GE Healthcare's Myoview (Tetrofosmin) cardiac imaging agent through Cardinal Health's network of specialized nuclear pharmacies, giving Cardinal Health's customers greater access to Myoview, a myocardial perfusion imaging technetium agent used in the diagnosis and treatment of heart disease.

March 21, 2008 — The Drug Information Association (DIA) will host an educational forum in conjunction with the FDA and the Heart Rhythm Society entitled 'QT and Arrhythmia Issues in Drug Development' from April 7-8, in Bethesda, MD, to focus on the new direction in the development of pharmaceutical agents for cardiac repolarization.

Specific areas of concentration will include:

March 20, 2008 – The number of CT procedures performed continues to grow despite a slow down in CT system purchases from 2000 to 2008 in the U.S. as CT sites focus on the efficient utilization of their CT equipment, indicated a report by the IMV Medical Information Division.
An estimated 68.7 million CT procedures were performed in 7,640 hospital and non-hospital sites in 2007, said the report. This represents an average annual growth rate of approximately 8 percent since 2003, when an estimated 50.1 million procedures were performed.

March 20, 2008 - ARUP Laboratories and the University of Utah's Department of Pathology have released ARUP Consult version 2.3, a free laboratory test selection support tool for PDA devices that includes more than 1,500 lab tests categorized into disease-related topics, including clinical background information, test ordering suggestions and concise diagnostic advice.

The LIFEPAK 1000 defibrillator/monitor is the most rugged defibrillator ever designed by Physio-Control, with an IP55 rating. ADAPTIV biphasic technology provides a range of energy up to 360 joules, and an upgradeable platform. The 1000 is equipped with cprMAX technology, enabling care providers to change protocols as standards of care evolve.

The LIFEPAK 12 defibrillator/monitor offers full-featured defibrillation and industry-standard monitoring for emergency services and hospitals. It utilizes ADAPTIV biphasic technology and combines semi-automatic and manual defibrillation. The 12 features capnography, external pacing, 12-lead electrocardiography and enhanced monitoring capabilities.

The LightSpeed VCT CT scanner for cardiac imaging reportedly reduces a patient�s radiation exposure by up to 70 percent for diagnostic cardiac scans, while maintaining optimal image quality.

The LightSpeed VCT XT captures images of the heart and coronary arteries in as few as five heartbeats. With new SnapShot Pulse technology, which applies a process called prospective triggered gating, an automated response to a patient�s heart rate ensures that the X-ray is only on for portions of a scan, thus significantly reducing a patient�s X-ray exposure time.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now